Jindal Hotels Share Price
Sector: Hotels & Motels
93.89 +1.58 (1.71%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
91.00
Today’s High
94.00
52 Week Low
81.00
52 Week High
141.35
Key Metrics
- Market Cap (In Cr) 65.73
- Beta 0.93
- Div. Yield (%) 0
- P/B 2.9
- TTM P/E 52.18
- Sector P/E 38.02
- D/E 0.02
- Open Price 91.01
- Prev Close 92.31
Jindal Hotels Analysis
Price Analysis
-
1 Week5.73%
-
3 Months8.86%
-
6 Month-5.91%
-
YTD-4.95%
-
1 Year-27.37%
Risk Meter
- 47% Low risk
- 47% Moderate risk
- 47% Balanced Risk
- 47% High risk
- 47% Extreme risk
Jindal Hotels News
Q4 results today: IRCTC, Deepak Nitrate, SAIL, Cummins, Bata India on May 28
2 min read . 28 May 2025Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more
2 min read . 27 May 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 12 Mar 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 06 Mar 2025Jindal Hotels Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 44.99
- Selling/ General/ Admin Expenses Total
- 8.66
- Depreciation/ Amortization
- 5.01
- Other Operating Expenses Total
- 19.21
- Total Operating Expense
- 41.85
- Operating Income
- 3.14
- Net Income Before Taxes
- 2.02
- Net Income
- 1.16
- Diluted Normalized EPS
- 1.65
- Period
- 2025
- Total Assets
- 82.13
- Total Liabilities
- 59.65
- Total Equity
- 22.47
- Tangible Book Valueper Share Common Eq
- 31.83
- Period
- 2025
- Cashfrom Operating Activities
- 12.96
- Cashfrom Investing Activities
- -3.85
- Cashfrom Financing Activities
- -7.53
- Net Changein Cash
- 1.58
- Period
- 2024
- Total Revenue
- 43.17
- Selling/ General/ Admin Expenses Total
- 8.12
- Depreciation/ Amortization
- 4.84
- Other Operating Expenses Total
- 15.52
- Total Operating Expense
- 36.61
- Operating Income
- 6.57
- Net Income Before Taxes
- 1.79
- Net Income
- 2.4
- Diluted Normalized EPS
- 3.37
- Period
- 2024
- Total Assets
- 81.95
- Total Liabilities
- 60.67
- Total Equity
- 21.28
- Tangible Book Valueper Share Common Eq
- 30.05
- Period
- 2024
- Cashfrom Operating Activities
- 10.18
- Cashfrom Investing Activities
- 0.68
- Cashfrom Financing Activities
- -10.92
- Net Changein Cash
- -0.06
- Period
- 2023
- Total Revenue
- 41.39
- Selling/ General/ Admin Expenses Total
- 7.16
- Depreciation/ Amortization
- 4.86
- Other Operating Expenses Total
- 15.42
- Total Operating Expense
- 35.57
- Operating Income
- 5.83
- Net Income Before Taxes
- 1.63
- Net Income
- 2.07
- Diluted Normalized EPS
- 2.84
- Period
- 2023
- Total Assets
- 86.61
- Total Liabilities
- 67.75
- Total Equity
- 18.86
- Tangible Book Valueper Share Common Eq
- 26.43
- Period
- 2023
- Cashfrom Operating Activities
- 10.8
- Cashfrom Investing Activities
- -2.12
- Cashfrom Financing Activities
- -8.61
- Net Changein Cash
- 0.07
- Period
- 2022
- Total Revenue
- 29.86
- Selling/ General/ Admin Expenses Total
- 5.62
- Depreciation/ Amortization
- 4.85
- Other Operating Expenses Total
- 11.25
- Total Operating Expense
- 28.58
- Operating Income
- 1.27
- Net Income Before Taxes
- -3.09
- Net Income
- -2.4
- Diluted Normalized EPS
- -3.63
- Period
- 2022
- Total Assets
- 88.34
- Total Liabilities
- 71.55
- Total Equity
- 16.79
- Tangible Book Valueper Share Common Eq
- 23.59
- Period
- 2022
- Cashfrom Operating Activities
- 6.01
- Cashfrom Investing Activities
- -13.84
- Cashfrom Financing Activities
- 5.95
- Net Changein Cash
- -1.88
- Period
- 2021
- Total Revenue
- 15.55
- Selling/ General/ Admin Expenses Total
- 4
- Depreciation/ Amortization
- 4.88
- Other Operating Expenses Total
- 8.55
- Total Operating Expense
- 21.64
- Operating Income
- -6.09
- Net Income Before Taxes
- -10.74
- Net Income
- -10.96
- Diluted Normalized EPS
- -17.54
- Period
- 2021
- Total Assets
- 81.81
- Total Liabilities
- 64.09
- Total Equity
- 17.72
- Tangible Book Valueper Share Common Eq
- 26.52
- Period
- 2021
- Cashfrom Operating Activities
- 0.17
- Cashfrom Investing Activities
- -1.42
- Cashfrom Financing Activities
- 1.99
- Net Changein Cash
- 0.74
- Period
- 2020
- Total Revenue
- 37.73
- Selling/ General/ Admin Expenses Total
- 8.31
- Depreciation/ Amortization
- 5.16
- Other Operating Expenses Total
- 12.15
- Total Operating Expense
- 32.14
- Operating Income
- 5.59
- Net Income Before Taxes
- 1.06
- Net Income
- 0.68
- Diluted Normalized EPS
- 1.03
- Period
- 2020
- Total Assets
- 84.51
- Total Liabilities
- 57.22
- Total Equity
- 27.29
- Tangible Book Valueper Share Common Eq
- 45.16
- Period
- 2020
- Cashfrom Operating Activities
- 11.31
- Cashfrom Investing Activities
- -1.96
- Cashfrom Financing Activities
- -8.44
- Net Changein Cash
- 0.91
- Period
- 2025-03-31
- Total Revenue
- 12.55
- Selling/ General/ Admin Expenses Total
- 2.17
- Depreciation/ Amortization
- 1.29
- Other Operating Expenses Total
- 5.51
- Total Operating Expense
- 11.89
- Operating Income
- 0.66
- Net Income Before Taxes
- 0.99
- Net Income
- 0.41
- Diluted Normalized EPS
- 0.59
- Period
- 2025-03-31
- Total Assets
- 82.13
- Total Liabilities
- 59.65
- Total Equity
- 22.47
- Tangible Book Valueper Share Common Eq
- 31.83
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 12.96
- Cashfrom Investing Activities
- -3.85
- Cashfrom Financing Activities
- -7.53
- Net Changein Cash
- 1.58
- Period
- 2024-12-31
- Total Revenue
- 14.23
- Selling/ General/ Admin Expenses Total
- 2.15
- Depreciation/ Amortization
- 1.26
- Other Operating Expenses Total
- 6.36
- Total Operating Expense
- 12.2
- Operating Income
- 2.02
- Net Income Before Taxes
- 2.93
- Net Income
- 2.4
- Diluted Normalized EPS
- 3.43
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 8.91
- Selling/ General/ Admin Expenses Total
- 2.23
- Depreciation/ Amortization
- 1.27
- Other Operating Expenses Total
- 4.05
- Total Operating Expense
- 9.31
- Operating Income
- -0.4
- Net Income Before Taxes
- -1.58
- Net Income
- -1.43
- Diluted Normalized EPS
- -2.05
- Period
- 2024-09-30
- Total Assets
- 82.42
- Total Liabilities
- 62.8
- Total Equity
- 19.62
- Tangible Book Valueper Share Common Eq
- 27.77
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 2.06
- Cashfrom Investing Activities
- -1.03
- Cashfrom Financing Activities
- -0.93
- Net Changein Cash
- 0.09
- Period
- 2024-06-30
- Total Revenue
- 9.31
- Selling/ General/ Admin Expenses Total
- 2.11
- Depreciation/ Amortization
- 1.19
- Other Operating Expenses Total
- 3.28
- Total Operating Expense
- 8.44
- Operating Income
- 0.87
- Net Income Before Taxes
- -0.32
- Net Income
- -0.23
- Diluted Normalized EPS
- -0.33
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 12.78
- Selling/ General/ Admin Expenses Total
- 2
- Depreciation/ Amortization
- 1.25
- Other Operating Expenses Total
- 4.38
- Total Operating Expense
- 9.82
- Operating Income
- 2.95
- Net Income Before Taxes
- 1.77
- Net Income
- 2.38
- Diluted Normalized EPS
- 3.9
- Period
- 2024-03-31
- Total Assets
- 81.95
- Total Liabilities
- 60.67
- Total Equity
- 21.28
- Tangible Book Valueper Share Common Eq
- 30.05
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 10.18
- Cashfrom Investing Activities
- 0.68
- Cashfrom Financing Activities
- -10.92
- Net Changein Cash
- -0.06
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Jindal Hotels Technical
Moving Average
SMA
- 5 Day91.75
- 10 Day90.43
- 20 Day90.21
- 50 Day91.9
- 100 Day90.16
- 300 Day94.8
Jindal Hotels Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Gujarat Hotels
- 275
- -5.45
- -1.94
- 375
- 194.15
- 105.64
- Royale Manor Hotels And Indust
- 49.43
- -1.01
- -2
- 65
- 35.33
- 98.03
- Jindal Hotels
- 93.89
- 1.58
- 1.71
- 141.35
- 81
- 65.73
- Indrayani Biotech
- 13.9
- 0.17
- 1.24
- 62.71
- 13.01
- 62.57
- Blue Coast Hotels
- 31.36
- -0.63
- -1.97
- 51.42
- 6.65
- 45.91
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Gujarat Hotels
- 19.66
- 2.15
- 9.8
- 134.44
- Royale Manor Hotels And Indust
- 31.69
- 1.6
- 4.86
- 13.68
- Jindal Hotels
- 56.45
- 2.9
- -7.77
- -4.42
- Indrayani Biotech
- -
- 0.87
- -
- -
- Blue Coast Hotels
- 2.13
- -
- -
- -
Jindal Hotels Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-Apr-25
- Audited Results
- 13-Feb-25
- Quarterly Results
- 22-Oct-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 26-Jul-24
- Quarterly Results
- 30-Apr-24
- Audited Results
- 23-Apr-24
- Audited Results
- 30-Jan-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 08-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 12-Aug-24
- AGM
- 26-Sept-23
- 05-Sept-23
- AGM
- 12-Jul-22
- 17-Jun-22
- AGM
- 22-Mar-22
- 22-Feb-22
- EGM



